Out-of-Pocket Spending Not Associated with Oral Oncolytic Survival Benefit

BACKGROUND: With total and out-of-pocket spending for oral oncolytics rising, there is increased interest in choosing oncology treatments based on their clinical value relative to cost. OBJECTIVE: To determine if out-of-pocket spending varied for higher versus lower benefit oral oncology drugs reimb...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotenstein, Lisa S., Dusetzina, Stacie B., Keating, Nancy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052860/
https://www.ncbi.nlm.nih.gov/pubmed/29799324
http://dx.doi.org/10.18553/jmcp.2018.24.6.494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052860/
https://www.ncbi.nlm.nih.gov/pubmed/29799324
http://dx.doi.org/10.18553/jmcp.2018.24.6.494

Ejemplares similares